148 related articles for article (PubMed ID: 29750782)
21. DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties.
Soares J; Espadinha M; Raimundo L; Ramos H; Gomes AS; Gomes S; Loureiro JB; Inga A; Reis F; Gomes C; Santos MMM; Saraiva L
Mol Oncol; 2017 Jun; 11(6):612-627. PubMed ID: 28296148
[TBL] [Abstract][Full Text] [Related]
22. Knockdown of FAM3B triggers cell apoptosis through p53-dependent pathway.
Mou H; Li Z; Yao P; Zhuo S; Luan W; Deng B; Qian L; Yang M; Mei H; Le Y
Int J Biochem Cell Biol; 2013 Mar; 45(3):684-91. PubMed ID: 23246487
[TBL] [Abstract][Full Text] [Related]
23. Spiro-oxindole derivative 5-chloro-4',5'-diphenyl-3'-(4-(2-(piperidin-1-yl) ethoxy) benzoyl) spiro[indoline-3,2'-pyrrolidin]-2-one triggers apoptosis in breast cancer cells via restoration of p53 function.
Saxena R; Gupta G; Manohar M; Debnath U; Popli P; Prabhakar YS; Konwar R; Kumar S; Kumar A; Dwivedi A
Int J Biochem Cell Biol; 2016 Jan; 70():105-17. PubMed ID: 26556313
[TBL] [Abstract][Full Text] [Related]
24. The transcription factor CREBZF is a novel positive regulator of p53.
López-Mateo I; Villaronga MÁ; Llanos S; Belandia B
Cell Cycle; 2012 Oct; 11(20):3887-95. PubMed ID: 22983008
[TBL] [Abstract][Full Text] [Related]
25. A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
Sturla LM; Cowan CW; Guenther L; Castellino RC; Kim JY; Pomeroy SL
Cancer Res; 2005 Jul; 65(13):5683-9. PubMed ID: 15994942
[TBL] [Abstract][Full Text] [Related]
26. Induction of p53 expression and apoptosis by a recombinant dual-target MDM2/MDMX inhibitory protein in wild-type p53 breast cancer cells.
Geng QQ; Dong DF; Chen NZ; Wu YY; Li EX; Wang J; Wang SM
Int J Oncol; 2013 Dec; 43(6):1935-42. PubMed ID: 24126697
[TBL] [Abstract][Full Text] [Related]
27. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
28. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
Shankar E; Sivaprasad U; Basu A
Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
[TBL] [Abstract][Full Text] [Related]
29. Mouse double minute antagonist Nutlin-3a enhances chemotherapy-induced apoptosis in cancer cells with mutant p53 by activating E2F1.
Ambrosini G; Sambol EB; Carvajal D; Vassilev LT; Singer S; Schwartz GK
Oncogene; 2007 May; 26(24):3473-81. PubMed ID: 17146434
[TBL] [Abstract][Full Text] [Related]
30. Escape from p53-mediated tumor surveillance in neuroblastoma: switching off the p14(ARF)-MDM2-p53 axis.
Van Maerken T; Vandesompele J; Rihani A; De Paepe A; Speleman F
Cell Death Differ; 2009 Dec; 16(12):1563-72. PubMed ID: 19779493
[TBL] [Abstract][Full Text] [Related]
31. Novel anthranilamide-pyrazolo[1,5-a]pyrimidine conjugates modulate the expression of p53-MYCN associated micro RNAs in neuroblastoma cells and cause cell cycle arrest and apoptosis.
Ramaiah MJ; Pushpavalli SN; Lavanya A; Bhadra K; Haritha V; Patel N; Tamboli JR; Kamal A; Bhadra U; Pal-Bhadra M
Bioorg Med Chem Lett; 2013 Oct; 23(20):5699-706. PubMed ID: 23992861
[TBL] [Abstract][Full Text] [Related]
32. MYCN-directed centrosome amplification requires MDM2-mediated suppression of p53 activity in neuroblastoma cells.
Slack AD; Chen Z; Ludwig AD; Hicks J; Shohet JM
Cancer Res; 2007 Mar; 67(6):2448-55. PubMed ID: 17363562
[TBL] [Abstract][Full Text] [Related]
33. Direct effects of Bmi1 on p53 protein stability inactivates oncoprotein stress responses in embryonal cancer precursor cells at tumor initiation.
Calao M; Sekyere EO; Cui HJ; Cheung BB; Thomas WD; Keating J; Chen JB; Raif A; Jankowski K; Davies NP; Bekkum MV; Chen B; Tan O; Ellis T; Norris MD; Haber M; Kim ES; Shohet JM; Trahair TN; Liu T; Wainwright BJ; Ding HF; Marshall GM
Oncogene; 2013 Aug; 32(31):3616-26. PubMed ID: 22907436
[TBL] [Abstract][Full Text] [Related]
34. Neurotrophin-3 promotes the cholinergic differentiation of sympathetic neurons.
Brodski C; Schnürch H; Dechant G
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9683-8. PubMed ID: 10931939
[TBL] [Abstract][Full Text] [Related]
35. The proapoptotic C16-ceramide-dependent pathway requires the death-promoting factor Btf in colon adenocarcinoma cells.
Rénert AF; Leprince P; Dieu M; Renaut J; Raes M; Bours V; Chapelle JP; Piette J; Merville MP; Fillet M
J Proteome Res; 2009 Oct; 8(10):4810-22. PubMed ID: 19705920
[TBL] [Abstract][Full Text] [Related]
36. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
37. Induction of neuronal apoptosis by expression of Hes6 via p53-dependent pathway.
Eun B; Cho B; Moon Y; Kim SY; Kim K; Kim H; Sun W
Brain Res; 2010 Feb; 1313():1-8. PubMed ID: 19968968
[TBL] [Abstract][Full Text] [Related]
38. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
[TBL] [Abstract][Full Text] [Related]
39. Phosphorylation of the Mdm2 oncoprotein by the c-Abl tyrosine kinase regulates p53 tumor suppression and the radiosensitivity of mice.
Carr MI; Roderick JE; Zhang H; Woda BA; Kelliher MA; Jones SN
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15024-15029. PubMed ID: 27956626
[TBL] [Abstract][Full Text] [Related]
40. BCL11B tumor suppressor inhibits HDM2 expression in a p53-dependent manner.
Obata M; Kominami R; Mishima Y
Cell Signal; 2012 May; 24(5):1047-52. PubMed ID: 22245141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]